Correction to: Low-chloride- versus high-chloride-containing hypertonic solution for the treatment of subarachnoid hemorrhage-related complications: The ACETatE (A low ChloriE hyperTonic solution for brain Edema) randomized trial.

[This corrects the article DOI: 10.1186/s40560-020-00449-0.].

Correction to: J Intensive Care 8, 32 (2020)

https://doi.org/10.1186/s40560-020-00449-0

Following the publication of the original article [1], it was noted that Fig. 3b had an erroneous graph. The correct Fig. 3 has been included in this correction. The authors apologize for this error.

Fig. 3

The effect of hypertonic solution on renal function and ICP reduction. a The rate of AKI was lower in the NaCl/Na-acetate group as compared with the NaCl group in an intention to treat analysis. b Comparison of Na+/Cl− loads with the study intervention doses, post-randomization. c Histogram of AKI frequency by group of treatment and hospitalization day. *p < 0.05. AKI, acute kidney injury; KDIGO, Kidney Disease: Improving Global Outcomes grading for AKI